J&J pulls file to extend Velcade's use in EU Pharma Times The drugmaker was seeking approval for the use of Velcade in combination with rituximab as a treatment for patients with relapsed follicular non-Hodgkin lymphoma. However, in a statement released by the European Medicines Agency, the regulator said it ... Janssen withdraws attempt to extend Velcade indication in EU Johnson & Johnson pulls EU submission for Velcade use in NHL EMA: Janssen-Cilag has Withdrew Extension Application for Velcade |
